Drugs / I123
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02418247 Comparator | May 2013 → Dec 2017 | thyroid tumor | National Cancer Center, Korea | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | I123 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02418247 ↗ |
| Modality | Diagnostic / imaging agent | “Diagnostic RAI (radioactive iodine I-123, 2-6mCi) will be given to achieve postRAI scan.” NCT02418247 ↗ |